Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Primary Phase	STARTED	Menhibrix Group	3,136
Primary Phase	STARTED	ActHIB Group	1,044
Primary Phase	COMPLETED	Menhibrix Group	2,888
Primary Phase	COMPLETED	ActHIB Group	961
Primary Phase	NOT COMPLETED	Menhibrix Group	248
Primary Phase	NOT COMPLETED	ActHIB Group	83
Fourth Dose Phase	STARTED	Menhibrix Group	2,769
Fourth Dose Phase	STARTED	ActHIB Group	923
Fourth Dose Phase	COMPLETED	Menhibrix Group	2,682
Fourth Dose Phase	COMPLETED	ActHIB Group	899
Fourth Dose Phase	NOT COMPLETED	Menhibrix Group	87
Fourth Dose Phase	NOT COMPLETED	ActHIB Group	24

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00289783/flow